Published in PLoS Negl Trop Dis on January 17, 2013
Chagas' disease: pregnancy and congenital transmission. Biomed Res Int (2014) 0.98
Immune Evasion Strategies of Trypanosoma cruzi. J Immunol Res (2015) 0.95
Acute chagas disease: new global challenges for an old neglected disease. PLoS Negl Trop Dis (2014) 0.93
The relationship between Chagas disease and immunosuppressive therapy. Blood Transfus (2013) 0.93
Endothelin-1 and its role in the pathogenesis of infectious diseases. Life Sci (2014) 0.86
Emerging and reemerging neglected tropical diseases: a review of key characteristics, risk factors, and the policy and innovation environment. Clin Microbiol Rev (2014) 0.83
Aptamer-based detection of disease biomarkers in mouse models for chagas drug discovery. PLoS Negl Trop Dis (2015) 0.80
Inhibitory effects of Trypanosoma cruzi sialoglycoproteins on CD4+ T cells are associated with increased susceptibility to infection. PLoS One (2013) 0.80
Putting Infection Dynamics at the Heart of Chagas Disease. Trends Parasitol (2016) 0.77
Meningoencephalitis Caused by Reactivation of Chagas Disease in Patient Without Known Immunosuppression. Am J Trop Med Hyg (2016) 0.75
Reactivation of Chagas Disease in a Patient With Follicular Lymphoma Diagnosed by Means of Quantitative Real-Time Polymerase Chain Reaction. Open Forum Infect Dis (2015) 0.75
A Novel Vaccine Approach for Chagas Disease Using Rare Adenovirus Serotype 48 Vectors. Viruses (2016) 0.75
The Role of Sialic Acid-Binding Receptors (Siglecs) in the Immunomodulatory Effects of Trypanosoma cruzi Sialoglycoproteins on the Protective Immunity of the Host. Scientifica (Cairo) (2013) 0.75
Evasion and Immuno-Endocrine Regulation in Parasite Infection: Two Sides of the Same Coin in Chagas Disease? Front Microbiol (2016) 0.75
Cryptosporidium infection in children with cancer undergoing chemotherapy: how important is the prevention of opportunistic parasitic infections in patients with malignancies? Parasitol Res (2017) 0.75
Evaluation and treatment of chagas disease in the United States: a systematic review. JAMA (2007) 5.22
A critical review on Chagas disease chemotherapy. Mem Inst Oswaldo Cruz (2002) 3.84
Chagas disease in Spain, the United States and other non-endemic countries. Acta Trop (2009) 3.22
International study to evaluate PCR methods for detection of Trypanosoma cruzi DNA in blood samples from Chagas disease patients. PLoS Negl Trop Dis (2011) 2.13
[Brazilian Consensus on Chagas disease]. Rev Soc Bras Med Trop (2005) 2.07
Successful treatment with posaconazole of a patient with chronic Chagas disease and systemic lupus erythematosus. Am J Trop Med Hyg (2010) 1.77
Chagas' disease: another cause of cerebral mass in the acquired immunodeficiency syndrome. Am J Med (1992) 1.64
Real-time PCR in HIV/Trypanosoma cruzi coinfection with and without Chagas disease reactivation: association with HIV viral load and CD4 level. PLoS Negl Trop Dis (2011) 1.58
Risk factors for Chagas' disease reactivation after heart transplantation. J Heart Lung Transplant (2008) 1.55
Tumour-like chagasic encephalitis in AIDS patients: an atypical presentation in one of them and outcome in a small series of cases. Arq Neuropsiquiatr (2008) 1.49
[Evaluation of cardiac function by radioisotopic angiography, in patients with chronic Chagas cardiopathy]. Arq Bras Cardiol (1985) 1.40
Reactivation of Chagas disease with central nervous system involvement in HIV-infected patients in Argentina, 1992-2007. Int J Infect Dis (2008) 1.38
Manifestations of Chagas disease (American trypanosomiasis) in patients with HIV/AIDS. Ann Trop Med Parasitol (2007) 1.29
Chagasic encephalitis in HIV patients: common presentation of an evolving epidemiological and clinical association. Lancet Infect Dis (2009) 1.23
Some aspects of protozoan infections in immunocompromised patients- a review. Mem Inst Oswaldo Cruz (2002) 1.20
Parasitic diseases of the heart. Front Biosci (2004) 1.17
Update in treatment of Chagas disease. Curr Opin Infect Dis (2011) 1.14
Chagas' disease and AIDS. Kinetoplastid Biol Dis (2004) 1.12
Pathology of patients with Chagas' disease and acquired immunodeficiency syndrome. Am J Trop Med Hyg (1994) 1.10
Recommendations for management of Chagas disease in organ and hematopoietic tissue transplantation programs in nonendemic areas. Transplant Rev (Orlando) (2011) 1.09
Trypanosoma cruzi parasitemia in chronic Chagas disease: comparison between human immunodeficiency virus (HIV)-positive and HIV-negative patients. J Infect Dis (2002) 1.05
Cerebral tumor-like American trypanosomiasis in acquired immunodeficiency syndrome. Ann Neurol (1999) 1.02
Reactivation of Chagas' disease in patients with AIDS: report of three new cases and review of the literature. Clin Infect Dis (1997) 1.00
Reactivation of Chagas' disease in a human immunodeficiency virus-infected patient leading to severe heart disease with a late positive direct microscopic examination of the blood. Am J Trop Med Hyg (1998) 0.97
[Protective effect of benznidazole against parasite reactivation in patients chronically infected with Trypanosoma cruzi and treated with corticoids for associated diseases]. Rev Soc Bras Med Trop (2000) 0.97
AIDS and Chagas' disease with central nervous system tumor-like lesion. Am J Med (1990) 0.96
Chagasic meningoencephalitis in a patient with acquired immunodeficiency syndrome: diagnosis, follow-up, and genetic characterization of Trypanosoma cruzi. Clin Infect Dis (2001) 0.94
Clinical analysis and parasite genetic diversity in human immunodeficiency virus/Chagas' disease coinfections in Brazil. Am J Trop Med Hyg (1999) 0.94
Simultaneous occurrence of acute myocarditis and reactivated Chagas' disease in a patient with AIDS. Clin Infect Dis (1995) 0.93
Chagas' disease encephalitis: intense CD8+ lymphocytic infiltrate is restricted to the acute phase, but is not related to the presence of Trypanosoma cruzi antigens. Clin Immunol (1999) 0.92
Heart transplantation in patients with Chagas' disease cardiomyopathy. J Heart Transplant (1988) 0.91
Chagas' disease and HIV co-infection in patients without effective antiretroviral therapy: prevalence, clinical presentation and natural history. Trans R Soc Trop Med Hyg (2010) 0.90
[Erythema nodoso in reactivation of Chagas' disease after cardiac transplantation]. Rev Soc Bras Med Trop (2005) 0.87
Chagas' disease and HIV co-infection: genotypic characterization of the Trypanosoma cruzi strain. Mem Inst Oswaldo Cruz (1998) 0.85
Polymyositis in Chagas's disease. Ann Rheum Dis (1978) 0.84
Association of uterine leiomyoma and Chagas' disease. Am J Trop Med Hyg (2002) 0.84
Follow-up of 18 patients with human immunodeficiency virus infection and chronic Chagas' disease, with reactivation of Chagas' disease causing cardiac disease in three patients. Clin Infect Dis (1998) 0.84
Chagas disease: another cause of cerebral mass in AIDS. Am J Med (1994) 0.84
Chagasic meningoencephalitis: case report of a recently included AIDS-defining illness in Brazil. Rev Inst Med Trop Sao Paulo (2004) 0.84
Reactivation of Chagas disease manifested by skin lesions in a patient with AIDS. Trans R Soc Trop Med Hyg (2000) 0.83
Guidelines on the treatment of chronic coinfection by Trypanosoma cruzi and HIV outside endemic areas. HIV Clin Trials (2011) 0.83
[Chagas disease and immunosuppression]. Medicina (B Aires) (1980) 0.82
Concurrent cerebral american trypanosomiasis and toxoplasmosis in a patient with AIDS. Clin Infect Dis (2004) 0.82
The relationship between megacolon and carcinoma of the colon: an experimental approach. Carcinogenesis (1996) 0.82
[Trypanosoma cruzi high parasitemia in patient with systemic lupus erythematosus]. Rev Soc Bras Med Trop (2003) 0.81
Successful treatment of Trypanosoma cruzi encephalitis in a patient with hemophilia and AIDS. Clin Infect Dis (1993) 0.81
Trypanosoma cruzi parasitemia observed in immunocompromised patients: the importance of the artificial xenodiagnosis. Rev Inst Med Trop Sao Paulo (2001) 0.81
Reactivation of cardiac Chagas' disease in acquired immune deficiency syndrome. Am J Cardiol (2004) 0.81
Immunocompromised host: from the early events until the impact of acquired immunodeficiency syndrome. Mem Inst Oswaldo Cruz (2000) 0.80
[Benznidazole in the primary chemoprophylaxis of the reactivation of Chagas' disease in chronic chagasic patients using corticosteroids at immunosuppressive doses: is there sufficient evidence for recommending its use?]. Rev Soc Bras Med Trop (2000) 0.80
Long-term follow-up after heart transplantation in Chagas' disease. Transplant Proc (1993) 0.80
Association of chagasic megacolon and cancer of the colon: case report and review of the literature. Rev Soc Bras Med Trop (2002) 0.79
[Reactivation of Trypanosoma cruzi infection in patients with acquired immunodeficiency syndrome]. Rev Soc Bras Med Trop (1999) 0.79
Treatment with benznidazole in association with immunosuppressive drugs in mice chronically infected with Trypanosoma cruzi: investigation into the possible development of neoplasias. Rev Soc Bras Med Trop (2003) 0.79
AIDS and Chagas' disease. AIDS Patient Care STDS (2000) 0.79
Chagasic megacolon associated with colon cancer. Am J Trop Med Hyg (1997) 0.78
Chagas' disease of the cervix uteri in a patient with acquired immunodeficiency syndrome. Hum Pathol (2000) 0.77
[Spontaneous chagasic peritonitis in a patient with AIDS]. Medicina (B Aires) (1998) 0.77
Organ transplantation and Chagas disease. JAMA (2008) 0.77
[Empirical anti-toxoplasma therapy in cerebral AIDS and Chagas disease. Presentation of 2 cases, review of the literature and proposal of an algorithm]. Medicina (B Aires) (1998) 0.77
Severe dengue virus infection in travelers: risk factors and laboratory indicators. J Infect Dis (2007) 2.92
Treatment of antineutrophil cytoplasmic antibody associated vasculitis: a systematic review. JAMA (2007) 2.91
Outcome predictors of pneumonia in elderly patients: importance of functional assessment. J Am Geriatr Soc (2004) 2.73
Clinical profile of Trypanosoma cruzi infection in a non-endemic setting: immigration and Chagas disease in Barcelona (Spain). Acta Trop (2009) 2.13
Screening for mutations related to atovaquone/proguanil resistance in treatment failures and other imported isolates of Plasmodium falciparum in Europe. J Infect Dis (2004) 1.99
[Antiphospholipid syndrome: analysis of 27 patients]. Med Clin (Barc) (2013) 1.98
Chagas disease and stroke. Lancet Neurol (2010) 1.79
Prevalence and vertical transmission of Trypanosoma cruzi infection among pregnant Latin American women attending 2 maternity clinics in Barcelona, Spain. Clin Infect Dis (2009) 1.78
Successful treatment with posaconazole of a patient with chronic Chagas disease and systemic lupus erythematosus. Am J Trop Med Hyg (2010) 1.77
Severe strongyloidiasis: a systematic review of case reports. BMC Infect Dis (2013) 1.70
Sedation for cardioversion in the emergency department: analysis of effectiveness in four protocols. Ann Emerg Med (2003) 1.66
Immunotherapy for antineutrophil cytoplasmic antibody-associated vasculitis: challenging the therapeutic status quo? Trends Immunol (2008) 1.64
Failure of standard treatment with praziquantel in two returned travelers with Schistosoma haematobium infection. Am J Trop Med Hyg (2006) 1.58
Etiology of diarrhea in children younger than 5 years of age admitted in a rural hospital of southern Mozambique. Am J Trop Med Hyg (2007) 1.57
Mortality in the catastrophic antiphospholipid syndrome: causes of death and prognostic factors in a series of 250 patients. Arthritis Rheum (2006) 1.53
First description of an Escherichia coli strain producing NDM-1 carbapenemase in Spain. Antimicrob Agents Chemother (2011) 1.48
Congenital transmission of Trypanosoma cruzi in Europe (Spain): a case report. Am J Trop Med Hyg (2006) 1.47
Low-dose aspirin vs low-dose aspirin plus low-intensity warfarin in thromboprophylaxis: a prospective, multicentre, randomized, open, controlled trial in patients positive for antiphospholipid antibodies (ALIWAPAS). Rheumatology (Oxford) (2013) 1.46
Lymphoplasmacytic lymphoma causing light chain cast nephropathy. Nephrol Dial Transplant (2012) 1.45
[Basic cardiopulmonary resuscitation program for high school students (PROCES). Results from the pilot program]. Med Clin (Barc) (2005) 1.42
Tolerance of benznidazole in treatment of Chagas' disease in adults. Antimicrob Agents Chemother (2010) 1.42
Congenital Trypanosoma cruzi infection in a non-endemic area. Trans R Soc Trop Med Hyg (2007) 1.41
Economic evaluation of Chagas disease screening of pregnant Latin American women and of their infants in a non endemic area. Acta Trop (2011) 1.36
Strongyloides stercoralis: a plea for action. PLoS Negl Trop Dis (2013) 1.33
Practical approach for typing strains of Leishmania infantum by microsatellite analysis. J Clin Microbiol (2002) 1.33
Etiology of diarrhea in children less than five years of age in Ifakara, Tanzania. Am J Trop Med Hyg (2004) 1.31
Benznidazole-related adverse drug reactions and their relationship to serum drug concentrations in patients with chronic chagas disease. Antimicrob Agents Chemother (2012) 1.22
The incidence of malaria in travellers to South-East Asia: is local malaria transmission a useful risk indicator? Malar J (2010) 1.15
High prevalence of symptomatic acute HIV infection in an outpatient ward in southern Mozambique: identification and follow-up. AIDS (2010) 1.14
Incidence and predictors of immune reconstitution inflammatory syndrome in a rural area of Mozambique. PLoS One (2011) 1.13
Congenital transmission of Chagas disease: a clinical approach. Expert Rev Anti Infect Ther (2010) 1.12
Etiopathogenesis of Behcet's disease. Autoimmun Rev (2009) 1.11
Biological markers for evaluating therapeutic efficacy in Chagas disease, a systematic review. Expert Rev Anti Infect Ther (2014) 1.11
Increased mortality in septic shock with the 4G/4G genotype of plasminogen activator inhibitor 1 in patients of white descent. Intensive Care Med (2007) 1.11
Recommendations for management of Chagas disease in organ and hematopoietic tissue transplantation programs in nonendemic areas. Transplant Rev (Orlando) (2011) 1.09
Mechanism of resistance to several antimicrobial agents in Salmonella Clinical isolates causing traveler's diarrhea. Antimicrob Agents Chemother (2004) 1.07
Socio-cultural aspects of Chagas disease: a systematic review of qualitative research. PLoS Negl Trop Dis (2013) 1.07
Severe valvular regurgitation and antiphospholipid antibodies in systemic lupus erythematosus: a prospective, long-term, followup study. Arthritis Rheum (2005) 1.07
Adalimumab for the treatment of Behçet's disease: experience in 19 patients. Rheumatology (Oxford) (2012) 1.05
A replication study confirms the association of TNFSF4 (OX40L) polymorphisms with systemic sclerosis in a large European cohort. Ann Rheum Dis (2010) 1.05
Use of noninvasive markers to detect Leishmania infection in asymptomatic human immunodeficiency virus-infected patients. J Clin Microbiol (2006) 1.05
Molecular surveillance of drug resistance through imported isolates of Plasmodium falciparum in Europe. Malar J (2002) 1.04
Effects of external and internal factors on emergency department overcrowding. Ann Emerg Med (2002) 1.04
Rituximab use in the catastrophic antiphospholipid syndrome: descriptive analysis of the CAPS registry patients receiving rituximab. Autoimmun Rev (2013) 1.04
Imported strongyloidiasis: epidemiology, presentations, and treatment. Curr Infect Dis Rep (2012) 1.02
Diagnostic techniques to detect cryptic leishmaniasis in dogs. Clin Diagn Lab Immunol (2002) 1.01
Factors influencing polyautoimmunity in systemic lupus erythematosus. Autoimmun Rev (2009) 0.99
Severe imported malaria in adults: retrospective study of 20 cases. Am J Trop Med Hyg (2009) 0.99
Catastrophic antiphospholipid syndrome and sepsis. A common link? J Rheumatol (2007) 0.99
Catastrophic antiphospholipid syndrome: proposed guidelines for diagnosis and treatment. J Clin Rheumatol (2002) 0.97
Leishmania infantum DNA detection in urine from patients with visceral leishmaniasis and after treatment control. Am J Trop Med Hyg (2008) 0.97
Chagas disease among the Latin American adult population attending in a primary care center in Barcelona, Spain. PLoS Negl Trop Dis (2011) 0.97
Trends in illicit drug emergencies: the emerging role of gamma-hydroxybutyrate. J Toxicol Clin Toxicol (2002) 0.96
A biomechanical analysis of ventral furrow formation in the Drosophila melanogaster embryo. PLoS One (2012) 0.96
Diagnosis, management and treatment of chronic Chagas' gastrointestinal disease in areas where Trypanosoma cruzi infection is not endemic. Gastroenterol Hepatol (2009) 0.95
Relapsing catastrophic antiphospholipid syndrome: report of three cases. Semin Arthritis Rheum (2007) 0.95
Antiphospholipid antibodies associated with malignancies: clinical and pathological characteristics of 120 patients. Semin Arthritis Rheum (2006) 0.95
Yellow fever-associated viscerotropic disease in Barcelona, Spain. J Travel Med (2008) 0.95
The clinical spectrum of catastrophic antiphospholipid syndrome in the absence and presence of lupus. J Rheumatol (2007) 0.95
Viscerotropic disease: case definition and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine (2012) 0.94
A systemic sclerosis and systemic lupus erythematosus pan-meta-GWAS reveals new shared susceptibility loci. Hum Mol Genet (2013) 0.94
Short-term follow-up of chagasic patients after benzonidazole treatment using multiple serological markers. BMC Infect Dis (2011) 0.94
Genetic structure of Phlebotomus (Larroussius) ariasi populations, the vector of Leishmania infantum in the western Mediterranean: epidemiological implications. Int J Parasitol (2010) 0.94
Intestinal involvement secondary to the antiphospholipid syndrome (APS): clinical and immunologic characteristics of 97 patients: comparison of classic and catastrophic APS. Semin Arthritis Rheum (2007) 0.93
Benznidazole for Chronic Chagas' Cardiomyopathy. N Engl J Med (2016) 0.93
[Utility of an immunochromatographic test for Chagas disease screening in primary healthcare]. Enferm Infecc Microbiol Clin (2009) 0.93
Vitamin K-dependent proteins GAS6 and Protein S and TAM receptors in patients of systemic lupus erythematosus: correlation with common genetic variants and disease activity. Arthritis Res Ther (2013) 0.93
Value of culture and nested polymerase chain reaction of blood in the prediction of relapses in patients co-infected with leishmania and human immunodeficiency virus. Am J Trop Med Hyg (2005) 0.93
Salmonella ovarian abscess following travel diarrhoea episode. Arch Gynecol Obstet (2007) 0.93
Molecular surveillance of the antifolate-resistant mutation I164L in imported African isolates of Plasmodium falciparum in Europe: sentinel data from TropNetEurop. Malar J (2003) 0.92
Epidemiology and management of refractory lupus nephritis. Autoimmun Rev (2011) 0.92
Update on the catastrophic antiphospholipid syndrome and the "CAPS Registry". Semin Thromb Hemost (2012) 0.92
Dynamics of Leishmania-specific immunoglobulin isotypes in dogs with clinical leishmaniasis before and after treatment. J Vet Intern Med (2006) 0.91
Chagas cardiomyopathy: the potential of diastolic dysfunction and brain natriuretic peptide in the early identification of cardiac damage. PLoS Negl Trop Dis (2010) 0.91
Identification of a Western blot pattern for the specific diagnosis of Trypanosoma cruzi infection in human sera. Am J Trop Med Hyg (2012) 0.91
Development of Escherichia coli rifaximin-resistant mutants: frequency of selection and stability. J Antimicrob Chemother (2008) 0.91
Evaluating Chagas disease progression and cure through blood-derived biomarkers: a systematic review. Expert Rev Anti Infect Ther (2013) 0.90
A multicenter study confirms CD226 gene association with systemic sclerosis-related pulmonary fibrosis. Arthritis Res Ther (2012) 0.90
Neuropsychiatric systemic lupus erythematosus: magnetic resonance imaging findings and correlation with clinical and immunological features. Autoimmun Rev (2013) 0.90
Confirmation of TNIP1 but not RHOB and PSORS1C1 as systemic sclerosis risk factors in a large independent replication study. Ann Rheum Dis (2012) 0.89
Tocilizumab treatment for refractory uveitis-related cystoid macular edema. Graefes Arch Clin Exp Ophthalmol (2013) 0.89
Therapeutic plasma exchange for the management of refractory systemic autoimmune diseases: report of 31 cases and review of the literature. Autoimmun Rev (2011) 0.89
Influence of the IL6 gene in susceptibility to systemic sclerosis. J Rheumatol (2012) 0.88
Hypercoagulability biomarkers in Trypanosoma cruzi -infected patients. Thromb Haemost (2011) 0.88
Confirmation of association of the macrophage migration inhibitory factor gene with systemic sclerosis in a large European population. Rheumatology (Oxford) (2011) 0.88
Behçet's disease in an HIV-1-infected patient treated with highly active antiretroviral therapy. Isr Med Assoc J (2006) 0.88
Catastrophic antiphospholipid syndrome: treatment, prognosis, and the risk of relapse. Clin Rev Allergy Immunol (2009) 0.87
Catastrophic antiphospholipid syndrome: diagnosis and management in pregnancy. Clin Lab Med (2013) 0.87
Epidemic Stevens-Johnson syndrome in HIV patients in Guinea-Bissau: a side effect of the drug-supply policy? AIDS (2010) 0.87
Catastrophic antiphospholipid syndrome: updated diagnostic algorithms. Autoimmun Rev (2010) 0.87